Prostate-specific membrane antigen-based imaging for stereotactic irradiation of low-volume progressive prostate cancer: a single-center experience
IntroductionProstate-specific membrane antigen (PSMA) is a transmembrane protein that may be expressed on the surface of prostate cancer (PC) cells. It enables a more sensitive and specific diagnosis PC, compared to conventional anatomical imaging.AimThe integration of PSMA-based imaging in the pers...
Main Authors: | Linda Varga, Zsuzsanna Besenyi, Viktor R. Paczona, István Farkas, Szabolcs Urbán, Gábor Sipka, László Pávics, Zoltan Varga, Emese Fodor, Katalin Hideghéty, Judit Olah, Zoltán Bajory, Anikó Maráz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1166665/full |
Similar Items
-
Diagnostic Performance of <sup>99m</sup>Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with <sup>18</sup>F-PSMA-1007 PET/CT
by: Joel E. Vargas-Ahumada, et al.
Published: (2023-12-01) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
by: Kristin A. Plichta, et al.
Published: (2021-11-01) -
Preliminary results of targeted prostate‐specific membrane antigen imaging in evaluating the efficacy of a novel hormone agent in metastatic castration‐resistant prostate cancer
by: Chang Liu, et al.
Published: (2020-05-01) -
Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
by: Carlos Artigas, et al.
Published: (2021-10-01) -
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
by: Heng-Chuan Su, et al.
Published: (2017-01-01)